Prognostic significance of AIF expression in diffuse large B-cell lymphoma
Background. Dysregulation of apoptosis in diffuse B-large cell lymphoma (DLBCL) contributes to increased tumor proliferation, as well as the formation of resistance to treatment. One of the most relevant areas of molecular research is the study of the mechanisms of programmed cell death – apoptosis....
Saved in:
| Main Authors: | Vitaly A. Rosin, Elena V. Vaneeva, Dmitriy A. Diakonov, Natalya V. Glubokovskikh, Svetlana V. Samarina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
"Consilium Medicum" Publishing house
2025-01-01
|
| Series: | Терапевтический архив |
| Subjects: | |
| Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/568946/203823 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunohistochemical Subtype and Parameters of International Prognostic Index in the New Prognostic Model of Diffuse Large B-Cell Lymphoma
by: SV Samarina, et al.
Published: (2019-09-01) -
The role of рАКТ1 expression in diffuse large B-cell lymphoma
by: E. V. Vaneeva, et al.
Published: (2021-10-01) -
Survival and Outcome of Patients with Diffuse Large B-cell Lymphoma According to the Central Nervous System–International Prognostic Index
by: Musa Fares Alzahrani, et al.
Published: (2025-07-01) -
Association of CDKN2A/B deletions with survival of patients with diffuse large B-cell lymphoma
by: M. V. Sarpova, et al.
Published: (2024-01-01) -
Association of CAR-T approval on outcomes in patients with diffuse large B-cell lymphoma at the population level in the United States
by: John L. Vaughn, et al.
Published: (2025-04-01)